Used in peptide synthesis as a protected amino acid derivative, particularly in the preparation of custom peptides for pharmaceutical research. The Fmoc group allows for mild base-labile protection, enabling stepwise assembly of peptide chains using solid-phase synthesis techniques. The hydrophobic cyclohexylphenyl side chain makes it suitable for introducing structural stability and specific binding interactions in bioactive peptides. Commonly employed in the development of enzyme inhibitors, receptor ligands, and therapeutic peptides where stereochemistry and side chain properties are critical.